Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

973
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
973

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

From Consensus to Regulatory End Point: Establishing Reference Standards as a Critical Step for Artificial Intelligence Software as Medical Devices.

Ophthalmology·2026
Same author

Clinical agents fail silently on patient identity.

International journal of medical informatics·2026
Same author

AI-induced never-skilling in medical education.

Nature medicine·2026
Same author

Peripheral retinal haemorrhage density on ultra-widefield imaging as a novel biomarker for predicting diabetic retinopathy progression: a 2-year longitudinal study in Asians.

The British journal of ophthalmology·2026
Same author

Using OCT Angiography to Predict Diabetic Retinopathy Progression and Vision Decline in a Multiethnic Cohort.

Ophthalmology science·2026
Same author

The evolving landscape of large language models and non-large language models in health care.

npj health systems·2026

Related Experiment Video

Updated: Oct 16, 2025

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

3.0K

Updates in deep learning research in ophthalmology.

Wei Yan Ng1,2, Shihao Zhang1, Zhaoran Wang2

  • 1Singapore National Eye Centre, Singapore Eye Research Institute, Singapore.

Clinical Science (London, England : 1979)
|October 18, 2021
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) in ophthalmology shows promise for disease classification but faces clinical translation barriers. Emerging techniques, ethical frameworks, and economic assessments are crucial for AI integration in eye care.

Keywords:
Artificial intelligencedeep learningneural networkophthalmology

More Related Videos

In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
07:44

In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography

Published on: July 24, 2020

3.1K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.7K

Related Experiment Videos

Last Updated: Oct 16, 2025

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography
04:48

Application of Deep Learning-Based Medical Image Segmentation via Orbital Computed Tomography

Published on: November 30, 2022

3.0K
In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography
07:44

In vivo Structural Assessments of Ocular Disease in Rodent Models using Optical Coherence Tomography

Published on: July 24, 2020

3.1K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

3.7K

Area of Science:

  • Ophthalmology
  • Medical Artificial Intelligence (AI)
  • Deep Learning (DL)

Background:

  • AI, particularly DL, is rapidly advancing in ophthalmology, driven by extensive data and digitized ocular images.
  • Current AI applications focus on classifying ophthalmic diseases like diabetic retinopathy, AMD, glaucoma, and ROP, aiding clinical decision-making.

Purpose of the Study:

  • To address the challenges hindering the clinical translation of AI-based Deep Learning Systems (DLSs) in ophthalmology.
  • To propose a multi-faceted approach combining technological advancements, regulatory compliance, ethical considerations, and economic evaluations for successful DLS implementation.

Main Methods:

  • Discusses the role of emerging AI techniques like federated learning (FL), generative adversarial networks (GANs), autonomous AI, and blockchain.
  • Highlights the importance of adhering to reporting and regulatory guidelines such as CONSORT-AI and STARD-AI.
  • Emphasizes the need for frameworks for patient consent, ethical assessment, and end-user perception evaluation, alongside health economic assessment (HEA).

Main Results:

  • Identifies key barriers to clinical translation: security/privacy concerns, poor generalizability, trust/explainability issues, end-user perception, and uncertain economic value.
  • Proposes that advanced techniques (FL, GANs, blockchain) can enhance privacy, collaboration, and DLS performance.
  • Stresses that regulatory compliance, ethical frameworks, and HEA are essential for transparency, reproducibility, and resource management.

Conclusions:

  • Clinical translation of AI in ophthalmology requires overcoming significant barriers beyond technical performance.
  • A combined strategy involving technological innovation, standardized reporting, ethical oversight, and economic viability is necessary for widespread adoption.
  • Integrating AI responsibly into ophthalmic practice necessitates careful consideration of privacy, trust, and financial implications to ensure patient benefit and efficient healthcare delivery.